TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback

Get the Brief in your inbox

A daily, SEC-grounded read on the market — movers, earnings, and our boldest calls. Free.

TTENK/calls

SEC-grounded equity research — opinionated calls reasoned over real filings.

Research

  • The Brief
  • Markets
  • All Stocks
  • Screener
  • Discover
  • Research
  • The Flip Side
  • Track record

Tools

  • Compare
  • Congress trades
  • Events
  • Filing search
  • Options calculator
  • Leaderboards
  • Insider trades
  • 13F funds
  • Groups
  • Trending
  • News

More

  • Pricing
  • Feedback
  • Newsletter
  • Developers / API
  • Account
DisclosuresTermsPrivacy

Research & education only — not financial advice.TENK is not a registered investment adviser; calls are impersonal, generated from SEC filings and a delayed/third-party price feed, and may be wrong or out of date. The operator and an affiliated trading operation may hold or trade the securities TENK rates — see Disclosures. Do your own research.

EDGAR® is a registered trademark of the U.S. Securities and Exchange Commission. TENK/calls is an independent service and is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.

TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback

Pulling SEC filings + quote and writing the call…

TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback
← New search
Home›Stocks›NEU
NEU logo

NEU

NEWMARKET CORP

Next earnings Jul 28, 2026

Last earnings -0.1% on 2026-04-22

Hold
$786.60
▼ -0.48%
$786.60▲ +16.44%
over 1Y
L $579.57H $862.03
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today-0.5%
1W-1.8%
1M+0.7%
3M+24.2%
YTD+15.4%
1Y+16.4%
OverviewFinancialsValuationQualityTimelineFilings
Rating
Hold
Quality
B-
Valuation
Overvalued
Filings
Watch
Hold
Conviction
Horizon
Medium (3–12mo)
12-mo target
$•••
Street · 8 analysts
Sell

High-return petroleum-additives specialist with a soft 2025 and a new specialty-materials leg; quality compounder at a fair 17.6x.

Revenue (FY2025) $2.73B · FY2025

The read

Middling fundamentals and a rich price (~47% above fair value) leave little margin of safety — a wait-and-see.

NewMarket is a high-quality petroleum-additives company (lubricant and fuel additives under the Afton/Ethyl franchises) whose FY2025 was a modest cyclical step-back. Consolidated net sales fell 2.2% to $2.73B and net income declined 9.4% to $419M ($44.44 diluted EPS), as petroleum-additives net sales dropped 3.9% on lower product shipments and selling prices, plus higher operating costs and one-time network-optimization charges. Management notes the decline was partly offset by lower raw-material costs, and the dip is best read as cyclical against a strong multi-year trend (net income rose from $191M in FY2021 to $462M in FY2024).

The quality of the franchise is the draw. Even in a down year, NewMarket earned a 20.0% operating margin, a 15.4% net margin, and a standout 23.5% ROE, and generated $569M of operating cash flow (up 9.5%) — well above its $77.6M capex and ample to fund $106M of dividends (up 10.5%) and $77.2M of buybacks (up 142%). The balance sheet strengthened: long-term debt fell 9.0% to $883M while equity grew 21.7% to $1.78B, taking liabilities/equity to a conservative 0.96x. Management explicitly states financial position 'remains strong' with sufficient capital access and comfortable debt covenants. No single customer is 10%+ of sales, reducing concentration risk.

Is NEU a buy? The one-page verdict, explained →

The options angle

model · matches our verdict
Covered call~60d expiry
  • Long 100 shares @ ~786.60
  • Short call 825 @ ~22.47 est
debit $76,413max +$6,087max −$76,412BE 764.13

HOLD means own it, don't chase it — harvesting premium against the position matches the verdict.

Open in the calculator →

Educational template, not a trade recommendation. Strikes and premiums are Black-Scholes model estimates from the last close and 30-day realized volatility — real chains, spreads and IV will differ. Options involve substantial risk.

Financials · annual, by fiscal year

Line itemFY21FY22FY23FY24FY25
Revenue$2.36B$2.76B$2.70B$2.79B$2.73B
Gross profit$548M$640M$773M$886M$857M
Operating income$258M$355M$483M$590M$544M
Net income$191M$280M$389M$462M$419M
Diluted EPS$17.71$27.77$40.44$48.22$44.44
Net margin8.1%10.1%14.4%16.6%15.4%

10-year statements — income, cash flow, balance sheet & CSV export →

Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.

Key statistics

Valuation

Enterprise value$8.04B
EV / EBITDA12.1
EV / Sales3.0
EV / FCF16.4
P / FCF14.7
PEG (trailing)—
Earnings yield5.8%
FCF yield6.8%

Quality & risk

ROIC (est.)16.1%
Free cash flow$491M
Total debt$883M
Net cash-$806M
Altman Z-Score4.72 safe
Piotroski F-Score5/9

Capital returns

Buyback yield1.1%
Dividend yield (est.)1.5%
Shareholder yield2.5%
Shares Δ YoY-1.3%

Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.

Disclosure timeline

SEC · 8-Ks + reports
Some governance/structural items recently, but no outright red flags.
  1. 8-K Shareholder vote2026-04-23
  2. 10-Q Quarterly report2026-04-23
  3. 8-K Earnings results2026-04-22
  4. DEF 14A Proxy statement2026-03-12
  5. 8-K Other event2026-02-26
  6. 8-K Officer / director change2026-02-26
  7. 8-K Officer / director change2026-02-18
  8. 10-K Annual report2026-02-12
  9. 8-K Earnings results2026-02-11

Recent filings

all on EDGAR ↗
4Period ending 2026-07-012026-07-01open ↗4Period ending 2026-07-012026-07-01open ↗4Period ending 2026-07-012026-07-01open ↗4Period ending 2026-07-012026-07-01open ↗4Period ending 2026-07-012026-07-01open ↗4Period ending 2026-06-182026-06-29open ↗4Period ending 2026-06-042026-06-08open ↗11-KPeriod ending 2025-12-312026-05-18open ↗SCHEDULE 13G/AFiling2026-05-14open ↗8-KPeriod ending 2026-04-232026-04-23open ↗10-QPeriod ending 2026-03-312026-04-23open ↗8-KPeriod ending 2026-04-222026-04-22open ↗

Quality score

B-
ValueGrowthProfitHealthMom.
ValueB
GrowthF
ProfitabilityA
Financial healthA-
MomentumB
  • ✗Revenue growing year-over-year
  • ✓Profitable (positive net income)
  • ✓Net margin above 10%
  • ✓Return on equity above 15%
  • ✓Liabilities below 2× equity
  • ✓P/E below 25

Fair value est.

$415.51

Overvalued -47% vs price

cheapfair valueexpensive

Modified Graham: EPS $44.44 × (8.5 + 1.5 × 0.0% growth) × 1.10 quality = 9.4× multiple. An estimate, not a price target.

579.5752-week862.03
Revenue
$2.73B
-2.2% YoY
Net margin
15.4%
ROE
23.5%
P/E
17.7

SEC fundamentals · FY 2025

'21'22'23'24'25

■ revenue · ■ net income, by fiscal year

Revenue$2.73B-2.2%
Net income$419M-9.4%
Gross profit$857M-3.3%
Operating income$544M-7.8%
Diluted EPS$44.44-7.8%
Cash & equivalents$77.6M+0.2%
Total assets$3.49B+11.6%
Total liabilities$1.71B+2.8%
Stockholders' equity$1.78B+21.7%
Gross: 31.5%Op.: 20.0%L/E: 0.96x

Frequently asked

Is NEWMARKET CORP (NEU) a buy?
NEU currently carries a Hold rating with 3/5 conviction, derived from its latest SEC filings. High-return petroleum-additives specialist with a soft 2025 and a new specialty-materials leg; quality compounder at a fair 17.6x.
What is NEU's fair value?
A Modified-Graham model based on NEU's SEC fundamentals estimates a fair value of about $415.51. It is an estimate from reported earnings, not a price target.
Is NEU overvalued or undervalued?
Against a Modified-Graham fair-value estimate, NEU currently appears overvalued relative to its SEC-grounded earnings power.
What is NEWMARKET CORP's quality score?
NEU scores 69.42406875293827/100 (grade B-) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.

Sources: SEC EDGAR (CIK 0001282637, latest 10-Q filed 2026-04-23) · EODHD · Proprietary analysis · as of 6/21/2026, 8:51:33 PM.

›About this recommendation — produced by TENK/calls (tenkcalls.com), Luxembourg · not investment advice

AI-generated analysis, produced by our proprietary engine from SEC filing data.

Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jun 21, 2026, 4:51 PM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.

Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.

Insider activity

Form 4 · SEC
2026-07-01
ROGERS JAMES E
Director
Award157.00
2026-07-01
GAMBILL MARK M
Director
Award157.00
2026-07-01
Harris H Hiter III
Director
Award157.00
2026-07-01
Ukrop Lowell Simmons
Director
Award157.00
2026-07-01
Xu Ting
Director
Award157.00
2026-06-18
GOTTWALD THOMAS E
Chairman, President & CEO
Gift211.00
2026-06-04
GOTTWALD THOMAS E
Chairman, President & CEO
Gift1.50K
2026-02-24
Xu Ting
Director
Buy400.00 @ $619.21$248K

Dividends

Quarterly
Yield (TTM)
1.5%
Annual / share
$11.75
Last ex-date
2026-06-15
Last amount
$3.00
ex 2026-06-15paid 2026-07-01$3.00
ex 2026-03-16paid 2026-04-01$3.00
ex 2025-12-15paid 2026-01-02$3.00
ex 2025-09-15paid 2025-10-01$2.75
ex 2025-06-16paid 2025-07-01$2.75
ex 2025-03-17paid 2025-04-01$2.75

Source: EODHD. Yield = trailing-12-month dividends ÷ price.

Earnings history

beat/miss · move
2026-04-22—▲ +8.29%8-K ↗
2026-02-11—▼ -16.47%8-K ↗
2025-10-30—▲ +2.12%8-K ↗
2025-07-30—▼ -4.44%8-K ↗
2025-04-23—▲ +8.07%8-K ↗
2025-02-03—▲ +4.05%8-K ↗

Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.

Congressional trades

all activity →

Disclosed under the STOCK Act

2019-09-16Josh GottheimerSell$1.00K–$15.0KPTR ↗
2019-09-16Josh GottheimerSell$1.00K–$15.0KPTR ↗
2019-05-20Josh GottheimerSell$1.00K–$15.0KPTR ↗
2019-04-15Nicholas Van TaylorSell$1.00K–$15.0KPTR ↗
2019-02-15Nicholas Van TaylorSell$1.00K–$15.0KPTR ↗
2019-01-31Josh GottheimerSell$1.00K–$15.0KPTR ↗

Self-reported periodic transaction reports (STOCK Act). Amounts are disclosed ranges; a trade may be a spouse's. Disclosures lag the trade by up to ~45 days. Source: House Clerk + Senate eFD.

Vs tracked universe

compare →

1194 tracked peers · median

TENK Score69 vs 67
Revenue growth-2.2% vs 7.5%
Net margin15.4% vs 10.0%
Return on equity23.5% vs 12.0%
P/E17.7 vs 26.2